Skip to content

Clinical trials

Completed Schizophrenia trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Status: Completed Country / region: Belgium Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20054
20075
20086
20091
20102
20112
20122
20134
20141
20151
20181
20191
20212

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed36

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC6
Janssen-Cilag International NV5
Otsuka Pharmaceutical Development & Commercialization, Inc.4
AstraZeneca3
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.3
Eli Lilly and Company2
Boehringer Ingelheim1
Cerevel Therapeutics, LLC1
Cliniques universitaires Saint-Luc- Université Catholique de Louvain1
FORUM Pharmaceuticals Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia36
Psychotic Disorders8
Bipolar Disorder4
Autistic Disorder1
Cognition Disorders1
Depressive Disorder1
Insulin Resistance1
Major Depressive Disorder1
Mania1
Neuroinflammatory Diseases1

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.